Patent | Date |
---|
Compositions For Treatment Of Substance Use Disorder App 20220233479 - FORSTER; Michael J. ;   et al. | 2022-07-28 |
System and method for measuring and controlling foot temperature Grant 11,357,282 - Cohen , et al. June 14, 2 | 2022-06-14 |
Inhibition Of Let7i As A Means To Enhance The Protective Effect Of Progesterone Against Stroke App 20220135975 - SINGH; MEHARVAN ;   et al. | 2022-05-05 |
Nitric Oxide Donor And Anti-oxidant Compounds App 20220073503 - ACHARYA; Suchismita | 2022-03-10 |
Inhibition of LET7I as a means to enhance the protective effect of progesterone against stroke Grant 11,230,711 - Singh , et al. January 25, 2 | 2022-01-25 |
Reconstituted Hdl Nanoparticles For Delivery Of Radioactive Agents And Uses Thereof App 20220008571 - LACKO; ANDRAS G. ;   et al. | 2022-01-13 |
Process For Engineering Targeted Nanoparticles App 20220008350 - VISHWANATHA; Jamboor K. ;   et al. | 2022-01-13 |
Compositions and methods for activation of NK cells killing of prostate cancer and breast cancer cells Grant 11,111,303 - Mathew , et al. September 7, 2 | 2021-09-07 |
Inhibition Of Ngly1 For The Treatment Of Cancer App 20210205349 - Wang; Yu-Chieh ;   et al. | 2021-07-08 |
Reprogramming Fibroblasts To Retinal Cells App 20210139844 - CHAVALA; Sai ;   et al. | 2021-05-13 |
Inhibition Of Let7i As A Means To Enhance The Protective Effect Of Progesterone Against Stroke App 20200216847 - SINGH; MEHARVAN ;   et al. | 2020-07-09 |
Engineered Cas9 Variants App 20200208129 - LIU; Jin ;   et al. | 2020-07-02 |
Enhanced Therapeutic Agent And Nucleic Acid Delivery Via Hdl Or Reconstituted Hdl Nanoparticles App 20200138727 - LACKO; ANDRAS G. ;   et al. | 2020-05-07 |
Devices, Systems, and Methods for Modeling Ocular Translaminar Pressure Gradients App 20190327958 - SHARMA; Tasneem Putliwala ;   et al. | 2019-10-31 |
System and Method for Measuring and Controlling Foot Temperature App 20190159546 - Cohen; Ian ;   et al. | 2019-05-30 |
Compositions And Methods For Activation Of Nk Cells Killing Of Prostate Cancer And Breast Cancer Cells App 20190071505 - Mathew; Purunelloor A. ;   et al. | 2019-03-07 |
Drug Delivery Vehicle App 20170333563 - Lacko; Andras G. ;   et al. | 2017-11-23 |
Composition Of Lipid-based Nanoparticles For Small Molecules And Macromolecules App 20170165200 - DONG; Xiaowei ;   et al. | 2017-06-15 |
Situ Self-assembling Pro-nanoparticle Compositions And Methods Of Preparation And Use Thereof App 20170112775 - DONG; Xiaowei | 2017-04-27 |
Multiple-pulse pumping for enhanced fluorescence detection and molecular imaging in cells and tissue Grant 9,612,245 - Rich , et al. April 4, 2 | 2017-04-04 |
Formulation of active agent loaded activated PLGA nanoparticles for targeted cancer nano-therapeutics Grant 9,555,011 - Braden , et al. January 31, 2 | 2017-01-31 |
FRET based multiplex probes Grant 9,388,450 - Gryczynski , et al. July 12, 2 | 2016-07-12 |
Drug delivery vehicle Grant 9,314,532 - Lacko , et al. April 19, 2 | 2016-04-19 |
Drug Delivery Vehicle App 20150343069 - Lacko; Andras G. ;   et al. | 2015-12-03 |
Curcumin-ER, a liposomal-PLGA sustained release nanocurcumin for minimizing QT prolongation for cancer therapy Grant 9,138,411 - Ranjan , et al. September 22, 2 | 2015-09-22 |
Curcumin-er, A Liposomal-plga Sustained Release Nanocurcumin For Minimizing Qt Prolongation For Cancer Therapy App 20150258026 - Ranjan; Amalendu Prakash ;   et al. | 2015-09-17 |
Formulation of Active Agent Loaded Activated PLGA Nanoparticles for Targeted Cancer Nano-Therapeutics App 20150209305 - Braden; Arthur R.C. ;   et al. | 2015-07-30 |
Multiple-pulse Pumping For Enhanced Fluorescence Detection And Molecular Imaging In Cells And Tissue App 20150011406 - Rich; Ryan M. ;   et al. | 2015-01-08 |
Compounds That Enable Alternative Mitochondrial Electron Transfer App 20140148446 - Simpkins; James W. ;   et al. | 2014-05-29 |
Curcumin-er, A Liposomal-plga Sustained Release Nanocurcumin For Minimizing Qt Prolongation For Cancer Therapy App 20140065061 - Ranjan; Amalendu Prakash ;   et al. | 2014-03-06 |
Drug Delivery Vehicle App 20140045950 - Lacko; Andras G. ;   et al. | 2014-02-13 |
Method of treating glaucoma comprising administering a composition comprising human BMP7 Grant 8,063,013 - Clark , et al. November 22, 2 | 2011-11-22 |
Method for treating glaucoma comprising administering to a patient in need thereof a composition comprising an antibody against gremlin Grant 7,744,873 - Clark , et al. June 29, 2 | 2010-06-29 |
Prodrugs for use as ophthalmic agents Grant 7,572,781 - Prokai , et al. August 11, 2 | 2009-08-11 |
Quinol compound and pharmaceutical composition Grant 7,534,779 - Prokai , et al. May 19, 2 | 2009-05-19 |
Bone morphogenic proteins (BMP), BMP receptors and BMP binding proteins and their use in the diagnosis and treatment of glaucoma Grant 7,405,192 - Clark , et al. July 29, 2 | 2008-07-29 |
Methods for diagnosing glaucoma and discovering anti-glaucoma drugs Grant 7,220,546 - Clark , et al. May 22, 2 | 2007-05-22 |
Prodrugs for use as ophthalmic agents Grant 7,186,707 - Prokai , et al. March 6, 2 | 2007-03-06 |
Modulation of intracellular calcium signaling by N-acylethanolamines App 20060142395 - Koulen; Peter ;   et al. | 2006-06-29 |
Immuno activation of CS1 receptor in natural killer cells to inhibit tumor cell growth Grant 7,041,499 - Mathew , et al. May 9, 2 | 2006-05-09 |
Steroidal quinols and their use for antioxidant therapy Grant 7,026,306 - Prokai , et al. April 11, 2 | 2006-04-11 |
Transgenic animal models for cardiac hypertrophy and methods of use thereof (treating) Grant 6,673,768 - Grant , et al. January 6, 2 | 2004-01-06 |
Transgenic mouse model for cardiac hypertrophy and methods of use thereof Grant 6,657,104 - Grant , et al. December 2, 2 | 2003-12-02 |
Endothelin antagonists and endothelin-converting enzyme inhibitors for the treatment of glaucoma App 20030176356 - Yorio, Thomas ;   et al. | 2003-09-18 |
Non-contracting tissue equivalent Grant 6,471,958 - Dimitrijevich , et al. October 29, 2 | 2002-10-29 |